Physician profile
Andrea Belt
NPI 1104298272
$2,504.75
in general payments reported to CMS, 2019-2025
17 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $592 · 2023: $663 · 2024: $449 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $538.77 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Otsuka America Pharmaceutical, INC. | $442.88 | 2021-2024 | Rexulti, Abilify Asimtufii |
| Abbvie INC. | $296.67 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $234.83 | 2022-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $196.56 | 2021-2025 | Spravato, Invega Sustenna |
| Neurocrine Biosciences, INC. | $179.84 | 2021-2025 | Ingrezza |
| Alkermes, INC. | $146.01 | 2021-2025 | Aristada, Lybalvi |
| Lundbeck LLC | $103.64 | 2021-2025 | Rexulti |
| Axsome Therapeutics, INC. | $103.39 | 2024-2025 | Auvelity, Sunosi |
| Tris Pharma INC | $67.10 | 2023 | Dyanavel Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $56.56 | 2022-2023 | Caplyta |
| Idorsia Pharmaceuticals US INC | $43.75 | 2022-2023 | Quviviq |
| Vanda Pharmaceuticals INC. | $31.03 | 2025 | Fanapt, Hetlioz |
| Merck Sharp & Dohme LLC | $18.64 | 2023 | Belsomra |
| Lilly USA, LLC | $16.92 | 2025 | Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $14.10 | 2022 | |
| Bausch Health US, LLC | $14.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Belt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.